Summary
Highlights
For decades, serotonin and norepinephrine were considered primary causes of depression. However, they couldn't fully explain symptoms. Scientists are now exploring other neurotransmitters like glutamate and GABA, which are abundant and regulate brain adaptation, as potential alternative causes for depression symptoms.
Severe and chronic stress, often experienced by individuals with depression, can lead to the loss of connections between nerve cells. This results in inefficient and noisy communication within brain circuits, particularly those regulating mood and emotion, contributing to the biology of depression.
Understanding the neurobiology of depression is crucial for two reasons: it helps in comprehending how the disease develops and progresses, and it enables the development of targeted treatments. Excitingly, effective treatment can restore a depressed brain to a healthy state.
Depression is often a long-term disorder, necessitating new and innovative treatments, especially for those who haven't responded to previous therapies. Psychiatry is entering a new era, shifting from the monoaminergic deficiency model to a more complete understanding of the brain as a complex neurochemical organ.
The standard understanding of depression has been based on the monoamine deficiency hypothesis, which suggests a deficit in neurotransmitters like serotonin or norepinephrine. However, there are over a hundred neurotransmitters and billions of neural connections, indicating this theory is limited.